InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

BCT Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$175,963.90
Insider Selling (Last 12 Months): C$0.00

BriaCell Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at BriaCell Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BriaCell Therapeutics Share Price & Price History

Current Price: C$10.60
Price Change: ▼ Price Decrease of -0.42 (-3.81%)
As of 12/31/2021 12:59 AM ET

This chart shows the closing price history over time for BCT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

BriaCell Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/28/2022Jamieson BondarenkoDirectorBuy28,000C$6.23C$174,566.34169,856
12/23/2022William WilliamsDirectorBuy519C$2.69C$1,397.5627,819
7/14/2022William WilliamsDirectorBuy27,272C$3.58C$97,497.4027,272
4/23/2021Gadi LevinSenior OfficerBuy2,000C$5.09C$10,187.762,810
4/23/2021William WilliamsDirectorBuy82,750C$4.14C$342,982.20149,636
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for BriaCell Therapeutics (CVE:BCT)

BriaCell Therapeutics logo
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Read More on BriaCell Therapeutics

Today's Range

Now: C$10.60
Low: C$10.60
High: C$11.07

50 Day Range

MA: C$10.60
Low: C$10.60
High: C$10.60

52 Week Range

Now: C$10.60
Low: C$3.50
High: C$15.75

Volume

3,402 shs

Average Volume

12,671 shs

Market Capitalization

C$168.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of BriaCell Therapeutics?

BriaCell Therapeutics' top insider investors include:
  1. Jamieson Bondarenko (Director)
  2. William Williams (Director)
Learn More about top insider investors at BriaCell Therapeutics.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.